A Comprehensive Review on Postmenopausal Osteoporosis in Women

被引:10
|
作者
Charde, Samruddhi H. [1 ]
Joshi, Abhishek [1 ]
Raut, Juhi [1 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Community Med, Wardha, India
关键词
management; bone; lifestyle; postmenopause; osteoporosis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURES; RISK-FACTORS; PRESERVATION; PREVENTION; WALKING; MANAGEMENT; DIAGNOSIS; EXERCISE;
D O I
10.7759/cureus.48582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In India, a sizeable share of the female population is in the postmenopausal or perimenopausal stage. Issues related to aging in women are an increased risk of broken bones, a decrease in cortical and cancellous bone thickness, and a decrease in bone mineral density (BMD). Osteoporosis has a severely detrimental effect on the life of women, lowering their standard of living, decreasing the quality of their lives, and increasing their likelihood of fractures. It can be terrible if the fracture affects the hip or the spine since it could leave you immobile. Postmenopausal osteoporosis is related to lack of estrogen and lack of eggs produced by ovaries seen with increasing age. After many years of study, the role of estrogen is now well established in bone remodelling. Estrogen contributes to the resorption and strengthening of bone. It detects less density of bone at specific site and helps in strengthening the bone at that location. Treatment choices are based on severity, rate of advancement, and individual patient-specific characteristics. By adopting a lifecycle approach, all women should be educated about this illness and inspired to adopt a healthy lifestyle that includes regular exercise and a balanced diet. All premenopausal women should be advised to take vitamin D and calcium supplements regardless of whether or not they have any bone defects. Smoking and alcohol consumption should also be restricted. Pharmacological intervention is carried out on patients diagnosed with the disease. Drugs should be chosen based on their side effects and contradictions. It's crucial to do follow-up, and patient compliance should be closely observed. This article raises awareness of this widespread illness and helps women of postmenopausal age take the required precautions to stop bone thinning and manage its progress; moreover, it also reviews the literature already published on it.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Osteoporosis and atherosclerosis in postmenopausal women
    Kuzmanova, S.
    Solakov, P.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S49 - S49
  • [22] Lasofoxifene in Postmenopausal Women with Osteoporosis
    Cummings, Steven R.
    Ensrud, Kristine
    Delmas, Pierre D.
    LaCroix, Andrea Z.
    Vukicevic, Slobodan
    Reid, David M.
    Goldstein, Steven
    Sriram, Usha
    Lee, Andy
    Thompson, John
    Armstrong, Roisin A.
    Thompson, David D.
    Powles, Trevor
    Zanchetta, Jose
    Kendler, David
    Neven, Patrick
    Eastell, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08): : 686 - 696
  • [23] Primary osteoporosis in postmenopausal women
    Ji Meng-Xia
    Yu Qi
    慢性疾病与转化医学(英文), 2015, 1 (01)
  • [24] Osteopenia and osteoporosis in postmenopausal women
    Çeliktas, M
    Kozanoglu, E
    Aikimbaev, KS
    Soyupak, S
    Binokay, F
    ACTA RADIOLOGICA, 2002, 43 (06) : 609 - 614
  • [25] Managing osteoporosis in postmenopausal women
    Vondracek, Sheryl F.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S9 - S19
  • [26] Osteoporosis as a Problem of Postmenopausal Women
    Supinova, M.
    Laukova, J.
    Bartosik, P.
    CLINICAL SOCIAL WORK AND HEALTH INTERVENTION, 2023, 14 (04): : 32 - 38
  • [27] Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review
    Shakeri, Ahmad
    Adanty, Christopher
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2020, 27 (01): : E25 - E31
  • [28] Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women
    Luis Perez-Castrillon, Jose
    Pinacho, Florentino
    De Luis, Daniel
    Lopez-Menendez, Maria
    Duenas Laita, Antonio
    JOURNAL OF OSTEOPOROSIS, 2010, 2010
  • [29] Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
    Gazoni, Fernanda Martins
    Civile, Vinicius Tassoni
    Atallah, Alvaro Nagib
    Santos, Fania Cristina
    Trevisani, Virginia Fernandes Moca
    SAO PAULO MEDICAL JOURNAL, 2023, 141 (06):
  • [30] Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature
    Wang-Chun Ho
    Chung-Chih Chang
    Wen-Tien Wu
    Ru-Ping Lee
    Ting-Kuo Yao
    Cheng-Huan Peng
    Kuang-Ting Yeh
    Current Rheumatology Reports, 2024, 26 : 188 - 195